← Eichor
Study identifier: NCT04652609 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program

Condition: Breast Neoplasm  ·  Sponsor: Universidad de Granada

PhaseNA
Planned participants25
Who can joinFemale, 18 Years to 70 Years
Healthy volunteersNo

About this study

The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.

This description comes directly from the study's public registry record.

Talk to the study team

Irene Cantarero-Villanueva, PhD  ·  958248764  ·  irenecantarero@ugr.es

Always discuss trial participation with your own doctor first.

Locations (1)

University of GranadaGranada, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04652609